Skip to main content

Animations

MJFF Publications

4431 - 4440 of 8436 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • Summary Details
    OPEN
    Title: The Parkinson's Disease Genome‐Wide Association Study Locus Browser
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28197
    Citation Count: 88
  • Summary Details
    OPEN
    Title: Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson's Disease
    Journal Name: The Journal of Neuroscience
    Publisher: Society for Neuroscience
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1523/jneurosci.1468-19.2020
    Citation Count: 42
  • Summary Details
    RESTRICTED
    Title: Dopamine-mediated improvements in dynamic balance control in Parkinson’s disease
    Journal Name: Gait & Posture
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.gaitpost.2020.08.132
    Best OA location URL:
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Impact of Off Periods on Persons With Parkinson Disease and Care Partners
    Journal Name: Neurology Clinical Practice
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/cpj.0000000000000921
    Citation Count: 7
  • Summary Details
    RESTRICTED
    Title: Striatal dopaminergic denervation and hypomimia in Parkinson's disease
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/ene.14483
    Best OA location URL:
    Citation Count: 4
  • Summary Details
    OPEN
    Title: The Impact of COVID‐19 on Access to Parkinson's Disease Medication
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28293
    Citation Count: 44
  • Summary Details
    RESTRICTED
    Title: The MPTP-lesioned marmoset model of Parkinson’s disease: proposed efficacy thresholds that may potentially predict successful clinical trial results
    Journal Name: Journal of Neural Transmission
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00702-020-02247-2
    Best OA location URL:
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Validation of differentially expressed brain‐enriched microRNAs in the plasma of PD patients
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.51146
    Citation Count: 53
  • Summary Details
    OPEN
    Title: Dopaminergic Nigrostriatal Connectivity in Early Parkinson Disease: In Vivo Neuroimaging Study of 11C-DTBZ PET Combined with Correlational Tractography
    Journal Name: Journal of Nuclear Medicine
    Publisher: Society of Nuclear Medicine
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.2967/jnumed.120.248500
    Citation Count: 26
  • Summary Details
    OPEN
    Title: First-in-Human Evaluation of 18F-SynVesT-1, a Radioligand for PET Imaging of Synaptic Vesicle Glycoprotein 2A
    Journal Name: Journal of Nuclear Medicine
    Publisher: Society of Nuclear Medicine
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.2967/jnumed.120.249144
    Citation Count: 94
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.